Periodontal regeneration of human infrabony defects. II. Re-entry procedures and bone measures
- PMID: 8483088
- DOI: 10.1902/jop.1993.64.4.261
Periodontal regeneration of human infrabony defects. II. Re-entry procedures and bone measures
Abstract
This paper evaluates the osseous healing response of 40 infrabony defects treated with guided tissue regeneration. The selected sites presented with deep periodontal lesions with a 1-, 2-, and 3-wall combination infrabony component of 6.1 +/- 2.5 mm. Baseline intrasurgical clinical measurements were compared with intrasurgical clinical measurements obtained at the 1 year surgical re-entry. A significant regeneration of bone of 4.3 +/- 2.5 mm was observed, along with a 0.4 +/- 1.9 mm resorption of the alveolar bone crest, which resulted in a 4.7 mm reduction of the original infrabony defect. Almost 90% of the sites showed a bone gain of 2 mm or more, while no site lost supporting bone; 73 +/- 31.2% of the original defect was filled with bone. The 3- and 2-wall components were filled 95 +/- 6.2% and 82 +/- 18.7% of their original depth, respectively; however, the 1-wall component was filled only 39 +/- 62.4%. It is concluded that treatment of infrabony defects according to the principles of guided tissue regeneration and a strict plaque control regimen resulted in clinically significant and highly predictable bone regeneration.
Similar articles
-
Periodontal regeneration of human infrabony defects. I. Clinical measures.J Periodontol. 1993 Apr;64(4):254-60. doi: 10.1902/jop.1993.64.4.254. J Periodontol. 1993. PMID: 8483087
-
Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.J Periodontol. 2002 Jan;73(1):3-12. doi: 10.1902/jop.2002.73.1.3. J Periodontol. 2002. PMID: 11846197 Clinical Trial.
-
Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. IV. A case series of infrabony defects after 10 years.J Periodontol. 2008 Aug;79(8):1491-9. doi: 10.1902/jop.2008.070571. J Periodontol. 2008. PMID: 18673000 Clinical Trial.
-
Comparison of porous and non-porous teflon membranes plus a xenograft in the treatment of vertical osseous defects: a clinical reentry study.J Periodontol. 2003 Aug;74(8):1161-8. doi: 10.1902/jop.2003.74.8.1161. J Periodontol. 2003. PMID: 14514229 Review.
-
Clinical applications of guided tissue regeneration: surgical considerations.Periodontol 2000. 1993 Feb;1:46-53. Periodontol 2000. 1993. PMID: 9673208 Review. No abstract available.
Cited by
-
Effects of L-PRF and A-PRF+ on periodontal fibroblasts in in vitro wound healing experiments.J Periodontal Res. 2020 Apr;55(2):287-295. doi: 10.1111/jre.12714. Epub 2019 Nov 28. J Periodontal Res. 2020. PMID: 31782171 Free PMC article.
-
Optimizing esthetic zone periodontal regeneration in a 1-2-wall infrabony defect using recombinant human platelet-derived growth factor BB and β-tricalcium phosphate: A case report.Clin Exp Dent Res. 2024 Jun;10(3):e908. doi: 10.1002/cre2.908. Clin Exp Dent Res. 2024. PMID: 38798052 Free PMC article.
-
A New Approach for Reconstruction of Severe Horizontal Atrophy of the Posterior Mandible Using "The Honeycomb Technique": A 10-14 Year Follow-Up Retrospective Study.J Clin Med. 2025 Mar 25;14(7):2246. doi: 10.3390/jcm14072246. J Clin Med. 2025. PMID: 40217697 Free PMC article.
-
Current Concepts in the Management of Periodontitis.Int Dent J. 2021 Dec;71(6):462-476. doi: 10.1111/idj.12630. Epub 2021 Feb 19. Int Dent J. 2021. PMID: 34839889 Free PMC article. Review.
-
Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 12-month randomized controlled trial.Clin Oral Investig. 2018 Nov;22(8):2819-2828. doi: 10.1007/s00784-018-2368-3. Epub 2018 Feb 6. Clin Oral Investig. 2018. PMID: 29411112 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources